Turning Point Therapeutics Reports Second-Quarter Financial Results, Provides Operational Updates

    NEXT STORY
    Tonix Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
    PREV STORY
    SCYNEXIS Reports Second Quarter 2020 Financial Results and Provides Company Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Once-weekly Trulicity® (dulaglutide) demonstrates significantly higher adherence and more persistence compared to once-weekly semaglutide and exenatide injections

    author_avatar
    NASDAQ Market News

    Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results

    Publication of PEDMARKTM SIOPEL 6 Clinical Data in The New England Journal of MedicineJoined ...

    author_avatar
    NASDAQ Market News

    Innovation Pharmaceuticals Announces Database Lock for Phase 2b Trial of Oral Prurisol for Psoriasis

    BEVERLY, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

    author_avatar
    NASDAQ Market News